Zobrazeno 1 - 10
of 53
pro vyhledávání: '"David C. Figge"'
Autor:
Jeffrey E. Grice, Benjamin E. Greer, Wui Jin Koh, Hisham K. Tamimi, Marit Ek, Howard G. Muntz, David C. Figge, Barbara A. Goff, Joanna M. Cain, Keith J. Stelzer
Publikováno v:
Gynecologic Oncology. 69:69-73
Objective. Earlier studies have demonstrated that the uterine papillary serous carcinoma (UPSC) variant of endometrial carcinoma has a high recurrence rate, even when disease is apparently confined to the uterus. The current study evaluated survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3232afbf539a9954a80887040e951d9b
https://doi.org/10.1006/gyno.1998.4956
https://doi.org/10.1006/gyno.1998.4956
Autor:
Barbara A. Goff, Thomas W. Griffin, Benjamin E. Greer, Hisham K. Tamimi, Wui Jin Koh, David C. Figge, Joanna M. Cain, Keith J. Stelzer
Publikováno v:
American Journal of Obstetrics and Gynecology. 172:1881-1888
Objective: Our purpose was to evaluate the contribution of intraoperative radiation therapy in the management of recurrent cervical cancer. Study design: Twenty-two patients were treated with electron beam intraoperative radiation therapy for recurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4863d288e58beaf3b9da25969053086a
https://doi.org/10.1016/0002-9378(95)91427-7
https://doi.org/10.1016/0002-9378(95)91427-7
Autor:
Joanna M. Cain, Barbara A. Goff, Rodney A. Schmidt, Daniel Kato, David C. Figge, Hisham K. Tamimi, Benjamin E. Greer, Judith A. Ferry, Marit Ek, Howard G. Muntz
Publikováno v:
Gynecologic Oncology. 54:264-268
Uterine papillary serous carcinoma (UPSC) is a distinct histologic type of endometrial cancer which is associated with a high relapse rate and poor prognosis. Between 1983 and 1993, 50 patients with UPSC of the endometrium were surgically staged. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::775e4ecbbd71c9084283b64a946c8b16
https://doi.org/10.1006/gyno.1994.1208
https://doi.org/10.1006/gyno.1994.1208
Autor:
David C. Figge, Joanna M. Cain, Wendy S. Brown, Hisham K. Tamimi, Benjamin E. Greer, Victoria L. Seewaldt, Sheree A. Miller
Publikováno v:
American Journal of Obstetrics and Gynecology. 170:1666-1671
Objective : Our aim was to determine the efficacy and toxicity of paclitaxel in the treatment of refractory and platinum-resistant epithelial ovarian cancer. Study Design : Eligibility required three prior failed chemotherapy regimens and documented
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14da3fa1598a9aaeef16b74abf80b1f
https://doi.org/10.1016/s0002-9378(94)70338-8
https://doi.org/10.1016/s0002-9378(94)70338-8
Publikováno v:
Obstetrics & Gynecology. 83:1015-1020
To determine whether tumors meeting the criteria of Hendrickson and Kempson for uterine smooth-muscle tumors of uncertain malignant potential have a natural history different from those of leiomyomas and leiomyosarcomas.Tumors with five to ten mitose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8406c443dd47dbea8c8a23f307ea4403
https://doi.org/10.1097/00006250-199406000-00023
https://doi.org/10.1097/00006250-199406000-00023
Autor:
Hisham K. Tamimi, H. James Wallace, Anthony H. Russell, Keith J. Stelzer, Joanna M. Cain, Wui Jin Koh, David C. Figge, Thomas W. Griffin, Kenneth J. Russell, Benjamin E. Greer
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 26:809-816
Purpose : To determine, in a retrospective single institutional study, the role of concurrent radiotherapy and chemotherapy in the treatment of local-regionally advanced vulvar cancer. Methods and Materials : From 1984 to 1991, 20 patients with local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a99e66635465206251dc5afcfe3dfc52
https://doi.org/10.1016/0360-3016(93)90496-i
https://doi.org/10.1016/0360-3016(93)90496-i
Publikováno v:
American Journal of Obstetrics and Gynecology. 166:1646-1654
OBJECTIVES: The histologic distinction of uterine benign leiomyomas from leiomyosarcomas is difficult. Ploidy analysis and measurement of the proliferative rate were examined to determine if they could distinguish malignant from benign tumors and if
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace26485e009b7a56bda6f99d6054084
https://doi.org/10.1016/0002-9378(92)91552-l
https://doi.org/10.1016/0002-9378(92)91552-l
Primary Central Nervous System Recurrence after Paclitaxel Therapy for Epithelial Ovarian Malignancy
Autor:
Joanna M. Cain, Wendy S. Brown, David C. Figge, Victoria L. Seewaldt, Benjamin E. Greer, Hisham K. Tamimi
Publikováno v:
Gynecologic Oncology. 55:456-458
Paclitaxel is currently being utilized to treat neoplasms which have a significant incidence of central nervous system metastases. It is, however, unclear as to whether paclitaxel crosses the blood-brain barrier. In this report, the authors describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::396ebd3e9de6f116a72062e8457965a5
https://doi.org/10.1006/gyno.1994.1322
https://doi.org/10.1006/gyno.1994.1322
Autor:
Victoria L. Seewaldt, Barbara A. Goff, Hisham K. Tamimi, Joanna M. Cain, David C. Figge, Benjamin E. Greer
Publikováno v:
Gynecologic oncology. 67(2)
Seven patients with gastrointestinal necrosis following paclitaxel chemotherapy are reported. Four of seven patients had platinum refractory disease, while 3/7 patients received primary paclitaxel therapy. Complications occurred 5 to 16 days followin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84909adb87d26747714c2b156ebd5a49
https://pubmed.ncbi.nlm.nih.gov/9367696
https://pubmed.ncbi.nlm.nih.gov/9367696
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancer
Autor:
David C. Figge, Stephen H. Petersdorf, Joanna M. Cain, Carolyn Collins, Hisham K. Tamimi, Robert B. Livingston, Benjamin E. Greer
Publikováno v:
American journal of obstetrics and gynecology. 174(6)
OBJECTIVES: A phase II trial of high-dose cyclophosphamide, etoposide, and cisplatin was done. STUDY DESIGN: Forty-eight patients with progressive or persistent disease and previous cisplatin-based chemotherapy and no paclitaxel therapy were entered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b3ef129fc0617f0cc42aee68fbebe1
https://pubmed.ncbi.nlm.nih.gov/8678128
https://pubmed.ncbi.nlm.nih.gov/8678128